Varicose Veins Treatment Devices Market Size & Growth Forecast 2027–2036, By Segments (Type, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Varicose Veins Treatment Devices Market size was assessed at USD 1.6 billion in 2026 and is poised to grow at a 5.99% CAGR between 2027 and 2036, crossing USD 2.86 billion by 2036. The industry revenue for 2027 is estimated at USD 1.68 billion.
Get more details on this report
Request Free Sample ReportVaricose Veins Treatment Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 47.70% of the market in 2026, supported by established vascular care pathways, broad access to minimally invasive procedures, and consistent demand across clinics and hospitals.
- Asia Pacific is projected to grow at a 7.23% CAGR as access to vascular treatment improves, minimally invasive procedures gain wider acceptance, and healthcare providers expand treatment capacity.
Segment Momentum
- Sclerotherapy held a 67.9% share in 2026 due to its established use for treating smaller varicose and spider veins, along with its suitability for efficient, office-based treatment workflows.
- Ambulatory Care Units are expanding rapidly as minimally invasive vein procedures increasingly shift to outpatient settings that offer efficient workflows, shorter patient turnaround times, and convenient treatment access.
Market Expansion Drivers
- Aging population and rising venous disease prevalence increasing treatment demand globally.
- Growing preference for minimally invasive vein treatment procedures improving patient outcomes.
- Expansion of outpatient vascular clinics and aesthetic vein correction services.
Leading Market Participants
- Top companies in the varicose veins treatment devices market include Medtronic plc (Ireland), Boston Scientific Corporation (United States), AngioDynamics, Inc. (United States), Teleflex Incorporated (United States), Merit Medical Systems, Inc. (United States), Biolitec AG (Austria), Sciton, Inc. (United States), Alma Lasers Ltd. (Israel), Dornier MedTech GmbH (Germany), Syneron Medical Ltd. (Israel).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.6 billion
- 2027 Estimated Market Size: USD 1.68 billion.
- Projected Market Size: USD 2.86 billion by 2036
- Growth Forecast: 5.99% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Sclerotherapy (Type) | Hospitals (End Use)
- Emerging Opportunity Segment: Endovenous Ablation (Type) | Ambulatory Care Unit (End Use)
Market Growth Drivers and Industry Trends
Aging population and rising venous disease prevalence increasing treatment demand globally
An aging population and the increasing prevalence of venous disorders will drive the varicose veins treatment devices market by expanding the number of patients requiring clinical intervention. As venous conditions become more prevalent, healthcare providers are placing greater emphasis on accessible treatment options that can address symptomatic and visible vein problems. This expanding patient pool supports demand for devices used in vein treatment procedures across clinical settings, while increasing awareness of available interventions can encourage more patients to seek professional care.
Growing preference for minimally invasive vein treatment procedures improving patient outcomes
Growing patient and provider preference for minimally invasive procedures will propel the varicose veins treatment devices market as treatment approaches increasingly emphasize reduced procedural burden and improved patient experiences. Devices designed for less invasive vein interventions can support treatment approaches that are more suitable for outpatient care while addressing clinical requirements associated with varicose veins. Greater acceptance of these procedures also encourages healthcare providers to adopt specialized equipment capable of supporting efficient treatment delivery and patient recovery.
Expansion of outpatient vascular clinics and aesthetic vein correction services
The expansion of outpatient vascular clinics and aesthetic vein correction services will boost the varicose veins treatment devices market by broadening the settings in which vein-related procedures are performed. Specialized clinics can provide dedicated treatment environments for patients seeking both medical management and correction of visible vein conditions, increasing the need for procedure-specific devices. As these services become more established, providers require equipment suited to efficient outpatient workflows and the treatment needs of patients pursuing vascular and aesthetic interventions.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of venous disorders & aging population | 2.40% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | High | Fast |
| Increasing adoption of minimally invasive treatment devices | 2.10% | Medium term (2–5 yrs) | Asia Pacific, North America (spillover: Europe) | Medium | Moderate |
| Advances in laser & radiofrequency ablation therapies | 1.70% | Long term (5+ yrs) | Europe, Asia Pacific (spillover: North America) | Medium | Slow |
| Aging population and rising venous disease prevalence increasing treatment demand globally | 2.00% | Low | Europe, North America, Asia Pacific | High | Near Term |
| Growing preference for minimally invasive vein treatment procedures improving patient outcomes | 1.50% | Moderate | North America, Europe | High | Near Term |
| Expansion of outpatient vascular clinics and aesthetic vein correction services | 1.00% | Low | Asia Pacific, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
Holding the largest share of the varicose veins treatment devices market, North America accounted for 47.70% in 2026, supported by advanced vascular care infrastructure, high adoption of minimally invasive procedures, and growing awareness of treatment options for venous disorders. Healthcare providers increasingly favor technologies that enable effective treatment with reduced recovery requirements compared with conventional surgical approaches. The region also benefits from access to specialized vascular specialists and well-equipped outpatient facilities capable of performing advanced procedures. In addition, rising attention to aesthetic appearance and improved quality of life is encouraging patients to seek treatment for symptomatic and visible varicose veins, while continued technological development is broadening the range of available device-based interventions.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, supported by improving access to specialized healthcare, increasing awareness of venous disorders, and expanding adoption of minimally invasive treatment technologies. Healthcare systems across the region are investing in modern diagnostic and therapeutic capabilities as demand for specialized vascular care increases. Urbanization and changing lifestyles are also contributing to greater awareness of chronic venous conditions and encouraging patients to seek professional treatment. Moreover, the expansion of private hospitals, specialty clinics, and outpatient treatment centers is improving access to advanced procedures. Growing physician familiarity with modern intervention techniques is further supporting the adoption of varicose veins treatment devices across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Treatment StandardsGermany prioritizes clinically validated varicose vein treatment devices that align with stringent vascular care standards. Hospitals and specialist clinics are investing in advanced ablation systems and procedural consistency to enhance treatment quality.
France 🇫🇷
Hospital Modernization FocusFrance continues upgrading vascular treatment capabilities through adoption of modern varicose vein treatment devices in hospital and specialty settings. Procurement priorities favor reliable systems that support standardized minimally invasive interventions.
Italy 🇮🇹
Specialist Clinic ExpansionItaly is seeing broader adoption of varicose vein treatment devices across specialized vascular clinics seeking efficient minimally invasive procedures. Healthcare providers are prioritizing equipment that supports patient comfort and streamlined treatment pathways.
Japan 🇯🇵
Aging Care IntegrationJapan is strengthening the use of varicose vein treatment devices as demand grows for therapies suited to an aging patient population. Providers are focusing on minimally invasive solutions that reduce recovery time while supporting efficient clinical workflows.
South Korea 🇰🇷
Technology-Driven Vein CareSouth Korea is incorporating advanced imaging and catheter-based technologies into varicose vein treatment practices. Medical providers are adopting devices that improve procedural precision while supporting high-volume vascular treatment centers.
United States 🇺🇸
Outpatient Procedure FocusThe U.S. market emphasizes minimally invasive varicose vein treatment devices that support outpatient procedures and faster patient recovery. Healthcare providers continue expanding adoption of image-guided technologies and integrated treatment platforms to improve procedural efficiency.
Segment Leadership and Growth Trends
Varicose Veins Treatment Devices Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Sclerotherapy (Largest Segment) vs Endovenous Ablation (Fastest-Growing Segment)
Sclerotherapy accounted for 67.9% of the varicose veins treatment devices market in 2026, reflecting its established role in treating varicose and spider veins through minimally invasive injection-based procedures. The technique is widely used because it can be performed without conventional surgery and is suitable for a broad range of venous conditions. Growing preference for less invasive treatment options, combined with the continuing need for effective management of superficial venous disease, supports the segment's strong position.
Endovenous ablation is anticipated to register the fastest growth as clinicians and patients increasingly favor minimally invasive approaches that can address problematic veins with limited disruption to surrounding tissue. Ablation techniques provide an alternative to conventional surgical treatment and can support efficient management of venous insufficiency, contributing to their growing clinical acceptance. Continued advances in catheter-based technologies and increasing preference for outpatient venous procedures are further supporting adoption.
End Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Care Unit (Fastest-Growing Segment)
Hospitals represented the largest end-use segment of the varicose veins treatment devices market in 2026, reflecting their established infrastructure for diagnosing and treating venous disorders. Hospitals provide access to specialized vascular expertise, imaging capabilities, procedural equipment, and postoperative care, enabling them to manage a broad range of varicose vein conditions. Their ability to support both routine and more complex interventions continues to sustain demand for treatment devices within hospital settings.
Ambulatory care unit is expected to grow at the fastest rate as varicose vein treatment increasingly shifts toward minimally invasive procedures that can be performed without prolonged inpatient stays. Ambulatory settings can offer greater convenience, efficient patient throughput, and reduced care intensity for appropriate venous interventions. The increasing preference for outpatient treatment and continued adoption of minimally invasive vascular techniques are creating favorable conditions for broader use of varicose vein treatment devices in these facilities.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Endovenous Ablation, Sclerotherapy, Surgical Ligation & Stripping | Sclerotherapy | Endovenous Ablation |
| End Use | Vein Clinics, Hospitals, Ambulatory Care Unit | Hospitals | Ambulatory Care Unit |
Competitive Landscape and Market Positioning
Leading companies in the varicose veins treatment devices market:
1. Medtronic plc (Ireland)
2. Boston Scientific Corporation (United States)
3. AngioDynamics Inc. (United States)
4. Teleflex Incorporated (United States)
5. Merit Medical Systems Inc. (United States)
6. Biolitec AG (Austria)
7. Sciton Inc. (United States)
8. Alma Lasers Ltd. (Israel)
9. Dornier MedTech GmbH (Germany)
10. Syneron Medical Ltd. (Israel)
In the varicose veins treatment devices market, minimally invasive approaches are gaining strong traction due to patient preference for faster recovery solutions. Device innovation is focusing on improving precision and treatment outcomes. The varicose veins treatment devices market continues to evolve with enhanced procedural efficiency and patient-centric care models.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| AngioDynamics Inc. (United States) | |||||||
| Teleflex Incorporated (United States) | |||||||
| Merit Medical Systems Inc. (United States) | |||||||
| Biolitec AG (Austria) | |||||||
| Sciton Inc. (United States) | |||||||
| Alma Lasers Ltd. (Israel) | |||||||
| Dornier MedTech GmbH (Germany) | |||||||
| Syneron Medical Ltd. (Israel). |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Varicose Veins Treatment Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Vein Disease Severity | Mild/Moderate Disease, Severe Disease, Recurrent/Complex Disease |
| Procedure Setting | Office-Based Vein Centers, Hospital-Based Procedures, Outpatient Ambulatory Settings |
| Technology Platform | Thermal Ablation Systems, Non-Thermal Ablation Systems, Injection-Based Systems |
Varicose Veins Treatment Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Minimally Invasive Procedure Opportunity Mapping |
|
| Physician Practice Evolution and Preference Analysis |
|
| Outpatient Care Expansion Opportunities |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the varicose veins treatment devices market?
How much is the varicose veins treatment devices industry expected to grow by 2036?
How are outpatient care models impacting the adoption of varicose veins treatment devices?
What is driving preference for minimally invasive techniques in varicose vein treatments?
Why does Sclerotherapy remain the leading treatment type in the varicose veins treatment devices market?
Why are Ambulatory Care Units the fastest-growing end users in the varicose veins treatment devices market?
Why does North America dominate the varicose veins treatment devices market?
What is driving growth in the varicose veins treatment devices market across Asia Pacific?
Who are the leading players in the varicose veins treatment devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization